Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Pyreos Heads East With Expanded Asia Operations

Published: Wednesday, April 03, 2013
Last Updated: Wednesday, April 03, 2013
Bookmark and Share
Scottish company adds ten South-East sales channel partners to cope with unprecedented demand for gesture sensor product.

Pyreos announces the 2nd stage of its global expansion has been completed, with the appointment of ten sales and distribution channel partners to support customers in Asia-Pac, to help deal with the exceptional interest levels in the Pyreos gesture sensor product from mobile phone and tablet computer manufacturers in China, Taiwan, Hong-Kong and Japan.

Vice President of Sales and Marketing Jeff Gray says: “There is phenomenal interest in our low power gesture sensor in that region, which has intensified since the introduction of the Galaxy 4 by Samsung which has gesture functionality. Many customers have told us that they see our gesture sensing as the lowest power and more long term solution for mobile and tablet devices that can work from close-up to a few meters of distance. It is great to add so many well established distribution partners to support our customers in their respective regions in Asia-Pac.”

Jeff Wright, CEO & Co-Founder of Pyreos comments: “These developments will ensure customers in Asia-Pac can rapidly access our gesture sensor products as well as our industrial sensor products and receive world class sales and customer support from our partners.”

Pyreos is a leading supplier of next generation infrared sensor products. Its unique, patented technology is enabling ground-breaking new applications including: touchless gesture control of mobile phones and tablet pcs; prevention of gear box failure in the engines of wind turbines, ships and helicopters; the early detection of serious medical illnesses, including diabetes and other life threatening conditions.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
When it Comes to Breast Cancer, Common Pigeon is No Bird Brain
If pigeons went to medical school and specialized in pathology or radiology, they’d be pretty good at distinguishing digitized microscope slides and mammograms of normal vs. cancerous breast tissue, a new study has found.
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Biomedical Imaging at One-Thousandth the Cost
Mathematical modeling enables $100 depth sensor to approximate the measurements of a $100,000 piece of lab equipment.
Improving Outcomes for Lung Cancer and Diabetic Patients
Novel technologies have been developed with support from SBRI Healthcare funding.
New Way of Detecting Cancer
A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Blood Test Picks Out Prostate Cancer Drug Resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos